Leen Ghonem

645 total citations
13 papers, 152 citations indexed

About

Leen Ghonem is a scholar working on Molecular Medicine, Infectious Diseases and Pharmacology. According to data from OpenAlex, Leen Ghonem has authored 13 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Medicine, 6 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Leen Ghonem's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antibiotic Use and Resistance (4 papers). Leen Ghonem is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Antibiotic Use and Resistance (4 papers). Leen Ghonem collaborates with scholars based in Saudi Arabia, United States and Canada. Leen Ghonem's co-authors include Mazin Barry, Awadh Alanazi, Thamer A. Almangour, Ahmed S. BaHammam, Sarah Alsubaie, Abdullah A. Alhifany, Fatimah Alshahrani, Fahad Almajid, Abdulkarim Alhetheel and Naif H. Alotaibi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and The Pediatric Infectious Disease Journal.

In The Last Decade

Leen Ghonem

11 papers receiving 151 citations

Peers

Leen Ghonem
Avnish Sandhu United States
Jesse Schnall Australia
Lai Chee Lee Singapore
Leen Ghonem
Citations per year, relative to Leen Ghonem Leen Ghonem (= 1×) peers David Luque-Paz

Countries citing papers authored by Leen Ghonem

Since Specialization
Citations

This map shows the geographic impact of Leen Ghonem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leen Ghonem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leen Ghonem more than expected).

Fields of papers citing papers by Leen Ghonem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leen Ghonem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leen Ghonem. The network helps show where Leen Ghonem may publish in the future.

Co-authorship network of co-authors of Leen Ghonem

This figure shows the co-authorship network connecting the top 25 collaborators of Leen Ghonem. A scholar is included among the top collaborators of Leen Ghonem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leen Ghonem. Leen Ghonem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Ghonem, Leen, et al.. (2024). Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients. European Journal of Clinical Pharmacology. 80(11). 1807–1817. 3 indexed citations
3.
Almangour, Thamer A., et al.. (2024). Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study. Journal of Infection and Chemotherapy. 30(10). 1008–1014. 1 indexed citations
4.
Almangour, Thamer A., et al.. (2023). Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrobial Agents and Chemotherapy. 67(8). e0040523–e0040523. 23 indexed citations
6.
7.
Almangour, Thamer A., Abdullah A. Alhifany, Khalid Eljaaly, et al.. (2021). Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective cohort study. International Journal of Infectious Diseases. 108. 406–412. 15 indexed citations
8.
Almangour, Thamer A., et al.. (2021). Ceftazidime-avibactam for the Treatment of Multidrug-resistant Pseudomonas aeruginosa Central Nervous System Infection in Pediatric Patient: A Case Report. The Pediatric Infectious Disease Journal. 41(5). 436–438. 10 indexed citations
9.
Hakeam, Hakeam A., Muhannad Alsemari, Zainab Al Duhailib, et al.. (2020). Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study. Journal of Cardiovascular Pharmacology and Therapeutics. 26(3). 244–252. 14 indexed citations
10.
Alsultan, Abdullah, Leen Ghonem, & Naif H. Alotaibi. (2020). Pharmacokinetics of Anti-tuberculous Drugs Delivered Via Nasogastric Tube Feeding in a Critically Ill Patient: A Case Study. Clinical Drug Investigation. 40(7). 675–678.
11.
Barry, Mazin, Fahad Almajid, Fatimah Alshahrani, et al.. (2020). Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area. Journal of Epidemiology and Global Health. 10(3). 214–214. 35 indexed citations
13.
Barry, Mazin, et al.. (2020). Coronavirus disease-2019 pandemic in the Kingdom of Saudi Arabia: Mitigation measures and hospital preparedness. SHILAP Revista de lepidopterología. 0(0). 0–0. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026